Novavax CEO Appointed to U.S.-India CEO Forum

On July 28, 2022 Novavax reported that Stanley C. Erck, President and Chief Executive Officer, Novavax, has been appointed by U.S. Secretary of Commerce Gina Raimondo to the U.S.-India CEO Forum (Forum) which brings together top-level business executives to discuss ways to strengthen the economic and commercial ties between the two countries, and to communicate their joint recommendations to the U.S. and Indian governments (Press release, Novavax, JUL 28, 2022, View Source [SID1234617143]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This appointment will provide Novavax’ CEO with the opportunity to lend insights based on his background of working extensively with some of India’s top business leaders. Further, Novavax will be a contributing partner in strengthening U.S. relationships with leaders in India and in a wide range of industries.

Established in 2005, the U.S.-India CEO Forum also informs government-to-government discussions, such as the U.S.-India Commercial Dialogue, on commercial affairs and highlights the strategic importance of the bilateral relationship.